» Articles » PMID: 34604060

Immunotherapeutic Potential of T Memory Stem Cells

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Oct 4
PMID 34604060
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Memory T cells include T memory stem cells (T) and central memory T cells (T). Compared with effector memory T cells (T) and effector T cells (T), they have better durability and anti-tumor immunity. Recent studies have shown that although T has excellent self-renewal ability and versatility, if it is often exposed to antigens and inflammatory signals, T will behave as a variety of inhibitory receptors such as PD-1, TIM-3 and LAG-3 expression, and metabolic changes from oxidative phosphorylation to glycolysis. These changes can lead to the exhaustion of T cells. Cumulative evidence in animal experiments shows that it is the least differentiated cell in the memory T lymphocyte system and is a central participant in many physiological and pathological processes in humans. It has a good clinical application prospect, so it is more and more important to study the factors affecting the formation of T. This article summarizes and prospects the phenotypic and functional characteristics of T, the regulation mechanism of formation, and its application in treatment of clinical diseases.

Citing Articles

Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming.

Dai Y, Liu Y, An L, Zhong F, Zhang X, Lou S J Immunother Cancer. 2024; 12(11).

PMID: 39551605 PMC: 11574435. DOI: 10.1136/jitc-2024-009949.


Alginate-based artificial antigen presenting cells expand functional CD8 T cells with memory characteristics for adoptive cell therapy.

Omotoso M, Est-Witte S, Shannon S, Li S, Nair N, Neshat S Biomaterials. 2024; 313:122773.

PMID: 39217794 PMC: 11423771. DOI: 10.1016/j.biomaterials.2024.122773.


A strategy to reconstitute immunity without GVHD via adoptive allogeneic Tscm therapy.

Guan L, Sun Y, Si Y, Yan Q, Han Z, Liu Y Front Immunol. 2024; 15:1367609.

PMID: 39035005 PMC: 11259968. DOI: 10.3389/fimmu.2024.1367609.


Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting.

Wan X, Wisskirchen K, Jin T, Yang L, Wang X, Wu X Clin Mol Hepatol. 2024; 30(4):735-755.

PMID: 38808361 PMC: 11540345. DOI: 10.3350/cmh.2024.0058.


Tuberculosis Vaccines and T Cell Immune Memory.

Li F, Dang W, Du Y, Xu X, He P, Zhou Y Vaccines (Basel). 2024; 12(5).

PMID: 38793734 PMC: 11125691. DOI: 10.3390/vaccines12050483.


References
1.
Martinez M, Moon E . CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment. Front Immunol. 2019; 10:128. PMC: 6370640. DOI: 10.3389/fimmu.2019.00128. View

2.
Ma E, Poffenberger M, Wong A, Jones R . The role of AMPK in T cell metabolism and function. Curr Opin Immunol. 2017; 46:45-52. DOI: 10.1016/j.coi.2017.04.004. View

3.
Verdon D, Mulazzani M, Jenkins M . Cellular and Molecular Mechanisms of CD8 T Cell Differentiation, Dysfunction and Exhaustion. Int J Mol Sci. 2020; 21(19). PMC: 7582856. DOI: 10.3390/ijms21197357. View

4.
Gattinoni L, Klebanoff C, Palmer D, Wrzesinski C, Kerstann K, Yu Z . Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J Clin Invest. 2005; 115(6):1616-26. PMC: 1137001. DOI: 10.1172/JCI24480. View

5.
Alvarez-Fernandez C, Escriba-Garcia L, Vidal S, Sierra J, Briones J . A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy. J Transl Med. 2016; 14(1):214. PMC: 4952071. DOI: 10.1186/s12967-016-0973-y. View